Thurston, Springer, Miller, Herd & Titak, Inc. Assertio Holdings, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $330 Million
- Q3 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 50,500 shares of ASRT stock, worth $51,005. This represents 0.02% of its overall portfolio holdings.
Number of Shares
50,500
Previous 12,500
304.0%
Holding current value
$51,005
Previous $15,000
293.33%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ASRT
# of Institutions
97Shares Held
31MCall Options Held
957KPut Options Held
38.5K-
Nantahala Capital Management, LLC New Canaan, CT8.95MShares$9.04 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$4.51 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.23MShares$3.27 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.4 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.26MShares$1.27 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $48.7M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...